Addatti BBC Afaan Oromoo waliin turtii taasiseen siyaasa Itoophiyaafi qabsoo egeree isaarratti bal'inaaan dubbateera.

Ilmaan Karrayyuu lamaan keessaa Quxusuu kan ta'e, warri Baasoo tibbana jila Buttaa Qaluu ardaa isaanii Tarree leediitti ...

Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next ...

The companies will leverage Bayer's expertise in developing medicines for heart conditions and Soufflé's siRNA delivery technologies to advance the treatment.

Ribo Life Science Co., Ltd. ("Ribo" or the "Company", stock code: 06938.HK), a leading company in small interfering RNA ...

In early January 2026, Bayer’s subsidiaries and partners reported a series of R&D advances, including FDA acceptance of ...

Bayer & Soufflé Therapeutics enter strategic collaboration to advance cell-specific heart-targeted siRNA therapy: Berlin, Germany Friday, January 9, 2026, 09:00 Hrs [IST] Bayer a ...

NEW YORK – Sarepta Therapeutics on Wednesday said it submitted an application to regulators in New Zealand, seeking to begin a first-in-human trial of SRP-1005, the siRNA drug it's developing for ...

Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration and global licensing agreement to ...

Corsera, which emerged in September 2025, aims to extend healthspan by reducing the risk of atherosclerotic cardiovascular ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the ...

SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...